Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
19,835,921
-
Share change
-
-11,052,807
-
Total reported value
-
$17,847,372
-
Put/Call ratio
-
0.75%
-
Price per share
-
$0.90
-
Number of holders
-
33
-
Value change
-
-$65,728,554
-
Number of buys
-
15
-
Number of sells
-
24
Institutional Holders of SATSUMA PHARMACEUTICALS INC - COM (STSA) as of Q4 2022
As of 31 Dec 2022,
SATSUMA PHARMACEUTICALS INC - COM (STSA) was held by
33 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
19,835,921 shares.
The largest 10 holders included
BML Capital Management, LLC, RA CAPITAL MANAGEMENT, L.P., NEA Management Company, LLC, VANGUARD GROUP INC, DRIEHAUS CAPITAL MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, TWO SIGMA INVESTMENTS, LP, ACADIAN ASSET MANAGEMENT LLC, RENAISSANCE TECHNOLOGIES LLC, and DIMENSIONAL FUND ADVISORS LP.
This page lists
33
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.